GLP-1s Are Growing In Popularity For Weight Loss But Losing Steam Among People With Diabetes, Study Suggests - Forbes
- GLP-1s Are Growing In Popularity For Weight Loss But Losing Steam Among People With Diabetes, Study Suggests Forbes
- Study indicates surge in GLP-1RA prescriptions to treat obesity and prevent its complications Medical Xpress
- Who’s taking Ozempic? New data reveals ‘significant’ shift, prompts shortage fears New York Post
- Most people taking GLP-1s like Ozempic are white women — plus 4 other takeaways from a new study Yahoo Life